Marval Biosciences' Series A Round

Marval Biosciences raised a round of funding on September 12, 2007.

Marval Biosciences is an early stage company, developing contrast agents for use in X-ray and Computed Tomography (CT) Imaging. Marval's lead candidate, NCTX, targets cardiovascular imaging.…

Articles about Marval Biosciences' Series A Round: